Document Detail


Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens.
MedLine Citation:
PMID:  7974318     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The efficacy of an antibiotic is related to its concentration at the site of infection. Previous studies of the concentrations of amoxycillin and clavulanic acid (co-amoxiclav) in respiratory secretions or whole lung tissue have suffered from methodological problems. The concentration of amoxycillin and clavulanic acid was determined in bronchial mucosal biopsy samples obtained at bronchoscopy following five different dosing regimens. METHODS: Bronchial biopsy and serum samples were obtained from 50 patients undergoing diagnostic bronchoscopy. Ten patients each received 375 mg, 625 mg, 750 mg, and 3.25 g oral, and 1.2 g intravenous co-amoxiclav 1-3 hours before bronchoscopy. The concentrations of clavulanic acid and amoxycillin were determined by high performance liquid chromatography using a microbore column, solid phase extraction, and preconcentration to improve sensitivity tenfold over previous methods. RESULTS: Concentrations of both clavulanic acid and amoxycillin in bronchial mucosa were dose related and were well above the MIC90 of co-amoxiclav for the common bacterial respiratory pathogens including Haemophilus influenzae, Micrococcus catarrhalis and Streptococcus pneumoniae for all dosing regimens. Mean mucosal levels were 200% and 118% of the corresponding serum levels for amoxycillin and clavulanic acid respectively. CONCLUSIONS: Amoxycillin and clavulanic acid are concentrated in bronchial mucosa and, even at the lowest dose of 375 mg orally, are likely to produce tissue levels in the lung sufficient to inhibit all the common community acquired respiratory pathogens.
Authors:
I M Gould; G Harvey; D Golder; T M Reid; S J Watt; J A Friend; J S Legge; J G Douglas
Related Documents :
24454838 - In vitro and in vivo enhancement of adipogenesis by italian ryegrass (lolium multifloru...
2883278 - The angle of internal flow as an indicator of filling and drug release properties of ca...
16331468 - Accumulation of gentisic acid as associated with systemic infections but not with the h...
10064568 - Distribution kinetics of salicylic acid in the dual-perfused rat liver preparation.
15543978 - Novel urea-linked cinchona-calixarene hybrid-type receptors for efficient chromatograph...
12091498 - Hplc-ms/ms analysis of the products generated from all-trans-retinoic acid using recomb...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thorax     Volume:  49     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  1994 Oct 
Date Detail:
Created Date:  1994-12-06     Completed Date:  1994-12-06     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  999-1001     Citation Subset:  IM    
Affiliation:
Department of Clinical Microbiology, Aberdeen Royal Infirmary, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amoxicillin / administration & dosage,  analysis,  pharmacokinetics
Amoxicillin-Potassium Clavulanate Combination
Bronchi / metabolism*
Bronchoscopy
Chromatography, High Pressure Liquid
Clavulanic Acids / administration & dosage,  analysis,  pharmacokinetics
Drug Administration Schedule
Drug Therapy, Combination / administration & dosage,  analysis,  pharmacokinetics*
Humans
Mucous Membrane / metabolism
Respiratory Tract Infections / prevention & control
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Clavulanic Acids; 26787-78-0/Amoxicillin; 74469-00-4/Amoxicillin-Potassium Clavulanate Combination
Comments/Corrections
Comment In:
Thorax. 1995 Apr;50(4):429   [PMID:  7785023 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic ...
Next Document:  Factors involved in the plasminogen activation system in human breast tumours.